Aptose Biosciences Inc. Made Headway
Fri, Dec 20, 2024 at 07:08 PM
Aptose Biosciences Inc. (APTO:NASDAQ) jumped higher at $0.28, a gain of 63.9%. On Fri, Dec 20, 2024, APTO:NASDAQ touched a New 2-Week High of $0.28. The stock appeared on our News Catalysts scanner on Thu, Dec 19, 2024 at 05:46 PM in the 'MISCELLANEOUS' category. From Fri, Dec 06, 2024, the stock recorded 30.00% Up Days and 9.09% Green Days
The stock spiked on Fri, Dec 20, 2024 at $0.39 with a volume of 304M+.
About Aptose Biosciences Inc. (APTO:NASDAQ)
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology.
Top 10 Gainers:
- Nvni Group Limited (NVNI:NASDAQ), 221.35%
- My Size, Inc. (MYSZ:NASDAQ), 212.5%
- Intchains Group Limited (ICG:NASDAQ), 106.84%
- TPI Composites, Inc. (TPIC:NASDAQ), 96.72%
- Syntec Optics Holdings Inc Cl A (OPTX:NASDAQ), 80.41%
- Vince Holding Corp. (VNCE:NYSE), 73.38%
- Aptose Biosciences Inc. (APTO:NASDAQ), 63.92%
- Edible Garden AG Incorporated (EDBL:NASDAQ), 63.48%
- HomesToLife Ltd (HTLM:NASDAQ), 49.4%
- The Marygold Companies Inc. (MGLD:NYSEMKT), 48.55%